Gordon Ringold - 29 Jul 2022 Form 3 Insider Report for Apexigen, Inc.

Reporting relationship
Director
Issuer ticker
N/A
Reported as of
29 Jul 2022
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
08 Aug 2022, 17:14:30 UTC
Next SEC filing
03 Oct 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Francis Sarena, by power of attorney

Key filing fact

Gordon Ringold filed Form 3 for Apexigen, Inc. on 08 Aug 2022.

Key facts

  • This page summarizes Gordon Ringold's Form 3 filing for Apexigen, Inc..
  • 0 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 08 Aug 2022, 17:14.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

APGN holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10,000
Date
29 Jul 2022
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

APGN holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
34,084
Exercise price
$4.59
Footnotes
F1
APGN holding Derivative

Warrants (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
29 Jul 2022
Ownership
Direct
Underlying class
Common Stock
Underlying amount
5,000
Exercise price
$11.50
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The shares subject to the option vest in 48 equal monthly installments beginning on June 8, 2020.

Footnote F2

The shares underlying the warrant become exercisable on August 28, 2022.

SEC remarks

Exhibit 24 - Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .